Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Michaelis

Showing results (71-80 of 214) with videos related to

Pageof 22
Sort By:
Journal of Medical Virology|December 13, 2022
Impact of the COVID-19 pandemic on the circulation of other pathogens in EnglandLauren J Hayes, Hannah Uri, Denisa Bojkova, et al.
Bioinformatics (Oxford, England)|May 17, 2019
Is the Bombali virus pathogenic in humans?Henry J Martell, Stuart G Masterson, Jake E McGreig, et al.
Medical Microbiology and Immunology|October 23, 2010
Oncomodulation by human cytomegalovirus: novel clinical findings open new roadsMartin Michaelis, Peter Baumgarten, Michel Mittelbronn, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 1, 2006
Ribavirin inhibits angiogenesis by tetrahydrobiopterin depletionMartin Michaelis, Ruth Michaelis, Tatyana Suhan, et al.
International Journal of Pharmaceutics|June 7, 2011
Treatment of glioblastoma with poly(isohexyl cyanoacrylate) nanoparticlesStefanie Wohlfart, Alexander S Khalansky, Christian Bernreuther, et al.
Pain|April 27, 2000
Tactile allodynia in the absence of C-fiber activation: altered firing properties of DRG neurons following spinal nerve injuryChang-Ning Liu, Patrick D Wall, Efrat Ben-Dor, et al.
Beilstein Journal of Nanotechnology|November 16, 2019
Incorporation of doxorubicin in different polymer nanoparticles and their anticancer activitySebastian Pieper, Hannah Onafuye, Dennis Mulac, et al.
Beilstein Journal of Nanotechnology|September 11, 2019
Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cellsHannah Onafuye, Sebastian Pieper, Dennis Mulac, et al.
International Journal for Parasitology. Drugs and Drug Resistance|December 7, 2021
Repurposing in vitro approaches for screening anti-parasitic drugs against the brain-eating amoeba Naegleria fowleriRubén Martín-Escolano, Lyto Yiangou, Eleanna Kazana, et al.
Bioinformatics (Oxford, England)|February 16, 2017
Changes associated with Ebola virus adaptation to novel speciesMorena Pappalardo, Ian G Reddin, Diego Cantoni, et al.
Pageof 22

Showing results (71-80 of 214) with videos related to

Sort By:
Pageof 22
Journal of Medical Virology|December 13, 2022
Impact of the COVID-19 pandemic on the circulation of other pathogens in EnglandLauren J Hayes, Hannah Uri, Denisa Bojkova, et al.
Bioinformatics (Oxford, England)|May 17, 2019
Is the Bombali virus pathogenic in humans?Henry J Martell, Stuart G Masterson, Jake E McGreig, et al.
Medical Microbiology and Immunology|October 23, 2010
Oncomodulation by human cytomegalovirus: novel clinical findings open new roadsMartin Michaelis, Peter Baumgarten, Michel Mittelbronn, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 1, 2006
Ribavirin inhibits angiogenesis by tetrahydrobiopterin depletionMartin Michaelis, Ruth Michaelis, Tatyana Suhan, et al.
International Journal of Pharmaceutics|June 7, 2011
Treatment of glioblastoma with poly(isohexyl cyanoacrylate) nanoparticlesStefanie Wohlfart, Alexander S Khalansky, Christian Bernreuther, et al.
Pain|April 27, 2000
Tactile allodynia in the absence of C-fiber activation: altered firing properties of DRG neurons following spinal nerve injuryChang-Ning Liu, Patrick D Wall, Efrat Ben-Dor, et al.
Beilstein Journal of Nanotechnology|November 16, 2019
Incorporation of doxorubicin in different polymer nanoparticles and their anticancer activitySebastian Pieper, Hannah Onafuye, Dennis Mulac, et al.
Beilstein Journal of Nanotechnology|September 11, 2019
Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cellsHannah Onafuye, Sebastian Pieper, Dennis Mulac, et al.
International Journal for Parasitology. Drugs and Drug Resistance|December 7, 2021
Repurposing in vitro approaches for screening anti-parasitic drugs against the brain-eating amoeba Naegleria fowleriRubén Martín-Escolano, Lyto Yiangou, Eleanna Kazana, et al.
Bioinformatics (Oxford, England)|February 16, 2017
Changes associated with Ebola virus adaptation to novel speciesMorena Pappalardo, Ian G Reddin, Diego Cantoni, et al.
Pageof 22